Developed a standardized
process for phytocomplex API
We are located in the Toscana Life Sciences (TLS) incubator in the GlaxoSmithKline research center, which provides space for nurturing startups in the life sciences.
This location provides access to costly infrastructure and technology that would otherwise be out of reach for startups, enabling us to effectively meet stringent pharmaceutical standards.
At TLS we have established our cutting-edge pharmaceutical production and quality control laboratory equipped with essential technical utilities, including air treatment, nitrogen gas, a chilling plant, purified water, a reception area, offices and meeting rooms.
Additionally, they offer a range of services including housekeeping, maintenance and waste disposal, while simultaneously offering an extensive scientific and business network.
First mover Italian pharma API manufacturer exclusively dedicated to the phytochemistry of the cannabis plant and the regulatory landscape
A small and flexible structure enables adaptation to an emerging market, providing a comprehensive offering of highly specialized, pharma-grade ingredients for galenic pharmacies and industrial partners
A robust industrial and medicalpharmaceutical network enables a clear and methodical regulatory and product deployment strategy
MMP: First in Pharmaceutical Cannabis
The field of cannabis phytochemistry has immense potential for innovative medicinal treatments. After decades of prohibition, the industry is experiencing rapid growth, while navigating the complexities of the plant, evolving regulations and novel pharmacological focus.
There is significant gap in the market of specialized medical cannabis companies in Italy with the capability to navigate the complexities of the regulatory landscape while providing patients with consistent, high-quality, and natural therapies targeting the endocannabinoid system.
To make the most of this opportunity in 2018 we created Materia Medica Processing, entering the market as with a skilled team, robust scientific network and extensive regulatory knowledge. We are now prepared to bring Active Pharmaceutical Ingredients (API) to the medical market tailored for specific therapeutic applications, conduct clinical trials, and enhance awareness within the medical community as the first Italian pharmaceutical cannabis company.